Skip to content

The Coronary AccEss After Tavi Registry - A Multicenter Prospective Registry for the Coronary Access After TAVI

The Coronary AccEss After Tavi Registry - A Multicenter Prospective Registry for the Coronary Access After TAVI

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04647864
Acronym
CAvEAT
Enrollment
600
Registered
2020-12-01
Start date
2021-01-28
Completion date
2022-12-01
Last updated
2021-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Valve Disease

Brief summary

The CAvEAT study is a not for profit, international, multicenter study aimed to assess the feasibility of selective coronary angiography (CA) after Transcatheter Aortic Valve Implantation (TAVI), to investigate predictors of successful selective cannulation (anatomical, technical, etc.) and to investigate if there is a significant difference among different type of transcatheter valves in selective coronary cannulation.

Interventions

DEVICETranscatheter Aortic Valve Implantation

Replacement of the aortic valve of the heart through the blood vessels, delivered via one of several access methods.

Sponsors

Fondazione GISE Onlus
CollaboratorOTHER
University of Padova
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Symptomatic aortic valve disease (stenosis or combined stenosis and regurgitation) candidate to TAVI according to local Heart Team evaluation, including valve-in-valve procedure due to degeneration of a previously implanted surgical bioprosthesis, who undergo coronary access in the same session of TAVI, immediately after transcatheter valve deployment (the procedures have to be consecutive); * Provision of signed informed consent; * Age ≥18 Years.

Exclusion criteria

* Chronic Kidney Disease stage IV-V (without dialytic treatment; otherwise, patients in dialytic treatment could be included); * Current participation in an interventional clinical study; * Age \< 18 years.

Design outcomes

Primary

MeasureTime frameDescription
Successful selective cannulation of both coronary arteriesImmediately after TAVISuccessful selective cannulation of both coronary arteries

Secondary

MeasureTime frameDescription
Successful selective cannulation of only left coronary arteryImmediately after TAVISuccessful selective cannulation of only left coronary artery (and no cannulation or sub selective cannulation of the contralateral)
Successful selective cannulation of only right coronary arteryImmediately after TAVISuccessful selective cannulation of only right coronary artery (and no cannulation or sub selective cannulation of the contralateral)

Countries

Italy

Contacts

Primary ContactMatteo Martinato, PhD
matteo.martinato@unipd.it+390498275646

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026